Cerebral embolism in the elderly
Cerebral embolism refers to an acute cerebrovascular disease caused by thrombi that enter the blood circulation blocking the cerebral arteries, accounting for 15% to 20% of strokes. Its onset age span is relatively large, with rheumatic heart disease causing most cases in young and middle-aged people, and coronary heart disease and large artery disease causing most cases in the elderly.
-
Site of disease:
Brain blood vessels -
Infectious :
Not contagious -
Frequent population:
Elderly -
Related symptoms:
Difficulty breathing Sensory disturbance Chest tightness Hemianopia Hemiplegia -
Concurrent disease:
Related Drugs
Ethyl polyacrylate capsules
Indication: Blood lipid drug. It has the effect of lowering serum triglycerides and total cholesterol and is used for hyperlipidemia.
Manufacturer:
KPC Pharmaceuticals, Inc.
Ligustrazine Phosphate Tablets
Indication: Used for ischemic cerebrovascular diseases, such as cerebral infarction caused by insufficient blood supply to the brain, cerebral thrombosis, and cerebral embolism.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Ligustrazine Phosphate Tablets
Indication: Used for ischemic cerebrovascular diseases, such as cerebral infarction caused by insufficient blood supply to the brain, cerebral thrombosis, and cerebral embolism.
Manufacturer:
GuangDongBangMinPharmaceutical Co., Ltd.
Troxerutin Sodium Chloride Injection
Indication: Used for ischemic cerebrovascular disease (such as cerebral thrombosis, cerebral embolism), central retinitis, arterial infection, coronary heart disease, thrombophlebitis, varicose veins, chronic venous insufficiency, etc.
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Naokangtai Capsules
Manufacturer:
Qinghai Geladandong Pharamceutical Co., Ltd.
Related Ingredients
-
EPA list
10417-94-4 -
LigustrazinePhosphate list
848645-86-3 -
Troxerutin list
7085-55-4 -
Riligustilide list
89354-45-0 -
1,1,3,3,5-PENTAMETHYL-4,6-DINITROINDANE list
116-66-5